Study Protocol for an International Pragmatic Randomised Controlled Trial of the NavCare-EU Intervention for Older People With Cancer and Their Family Caregivers
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 489
- 主要终点
- Global health status/quality of life of the older person with cancer
研究概览
简要总结
Most people with cancer are older, and this affects millions of Europeans yearly. Integrating high-quality, equitable, and cost-effective care across the continuum of supportive, palliative, and end-of-life care for both patients and family caregivers is highly relevant from a healthcare, prevention, and economic perspective.
EU NAVIGATE is an interdisciplinary, cross-country, and intersectoral project funded by the European Union. The overall aim of the study is to evaluate the effectiveness and cost-effectiveness of a patient and family navigation intervention (NavCare-EU) for older people with cancer and declining health and their family caregivers in different healthcare systems in Europe. Nav-Care EU is a person- and family-centered non-pharmacological intervention in which navigators collaborate with patients and families to improve quality of life and improve levels of social support, foster empowerment, and facilitate timely and equitable access to health and social care services and resources as needed, throughout the supportive and palliative care continuum. NavCare-EU is based on the existing and successfully tested Nav-CARE(c) intervention from Canada.
Effectiveness and cost-effectiveness will be evaluated through an international 6-country multisite pragmatic fast-track randomised controlled trial (RCT) with an embedded mixed methods process evaluation to compare the NavCare-EU intervention in addition to standard care with the provision of standard care alone. The RCT and process evaluation will be conducted in Belgium (Flanders), Ireland, Italy, the Netherlands, Poland, and Portugal. Participants are people with cancer and declining health, who are aged 70 years and older, as well as their close family caregivers.
Specific objectives are:
-
To compare the NavCare-EU intervention to care as usual, in terms of its:
-
Effectiveness on (1) global health status/quality of life, and the levels of social support (two co-primary outcomes); and on feelings of loneliness of older persons with cancer across the continuum of supportive, palliative, and end-of-life care; (2) family caregiver burden
-
cost-effectiveness
-
effects on different subgroups defined by characteristics known to affect health equity and equitable access, i.e., gender, age, socioeconomic status, extent of social support and living situation, and geographical location (rural vs. urban)
-
effectiveness and cost-effectiveness in different health care systems and care regimes in Europe
-
To evaluate the implementation processes of the NavCare-EU intervention and the feasibility of its integration in different health care systems and care regimens in Europe, the contextual barriers and facilitators for effective and sustainable implementation, and the mechanisms involved in reaching the outcomes in each country, as perceived by patients, family caregivers, and other care providers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 70 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •For older person with cancer
- •Inclusion criteria
- •Have a cancer diagnosis (active cancer, meaning not being cancer free, of any stage and involving any treatment/care regimen; i.e. curative, life-extending, or palliative), AND
- •Aged 70 years or over, AND
- •Have declining or deteriorating health using the Clinical Frailty Scale, AND
- •Live at home (own home or home of the family caregiver) (or discharged home if recruited in hospital), AND
- •Live within the catchment area of the navigation programme/service
排除标准
- •The close family caregiver living with the person with cancer or providing care at least on a weekly basis, and identified as the primary family caregiver by the person with cancer, if present, does not agree to participate in the study (unless participation is explicitly requested by the patient) , OR
- •Lives in a care or nursing home, or is incarcerated, OR
- •Currently receives care from a formally recognized community-based multidisciplinary or specialist palliative care team, OR
- •Is unable to provide informed consent or has difficulties understanding the information about the study , OR
- •Has a psychiatric condition (i.e. schizophrenia, bipolar disorder, or major depressive disorder) OR has an active substance abuse disorder OR
- •Is not able to participate in data collection in the country's language
- •For close family caregiver (if present)
- •Inclusion criteria
- •Aged 18 years or over , AND
- •Lives with the person with cancer OR provides care at least on a weekly basis, AND
- •Identified as primary family caregiver by the older person with cancer
- •Exclusion criteria
- •Is unable to provide informed consent or has difficulties understanding the information about the study, OR
- •Is not able to participate in data collection in the country's language
研究组 & 干预措施
intervention group
In EU NAVIGATE, participants in the intervention group will receive a navigation intervention (also called NavCare-EU), alongside any usual care. Navcare-EU is a person- and family-centered navigation intervention, aimed at supporting older people with cancer throughout the care and illness continuum, via the involvement of a patient/family navigator. Navigators focus on connecting clients to social supports, both formal and informal, advocating for clients in meeting their quality-of-life goals, resourcing by identifying needs and negotiating access to meeting those needs, and engaging clients in what is most meaningful to them. Navigators are selected, trained, and mentored volunteers or professionals. NavCare-EU is based on the existing and successfully tested Nav-CARE(c) intervention from Canada.
干预措施: NavCare-EU (Behavioral)
control group
Participants in the control group will receive what is usual care in each of the participating countries for 24 weeks (primary trial outcome). After 24 weeks, they will also receive the navigation intervention (NavCare-EU) (fast-track RCT).
结局指标
主要结局
Global health status/quality of life of the older person with cancer
时间窗: Change from baseline at 24 weeks.
Global health status/quality of life of the older person with cancer, measured with 2-item subscale from the EORTC-QLQ-C30 (revised) measuring health-related quality of life.
Levels of social support of the older person with cancer
时间窗: Change from baseline at 24 weeks.
Levels of social support of the older person with cancer measured with the Medical Outcomes Study Social Support Survey (MOS)
次要结局
- Caregiver burden of close family caregivers(Change from baseline at 24 weeks.)
- Feelings of loneliness of the older person with cancer(Change from baseline at 24 weeks.)
研究者
Lieve Van den Block
Professor of ageing and palliative care
Vrije Universiteit Brussel